Javascript must be enabled to continue!
A possible explanation for resistance in schizophrenia
View through CrossRef
IntroductionArachnoid cyst is a neurological tumor. It’s rare and benign. Its association to psychosis has been described in literature.ObjectivesThrough a case report and a review of the literature we hypothesize that arachnoid cyst is the cause of resistance in a patient with schizoaffective disorder.MethodsStarting from a case report, we conducted a literature review on “PubMed”, using key words “arachnoid cyst”, “arachnoid cyst a psychiatry”, “arachnoid cyst and schizoaffective disorder”, “arachnoid cyst and schizophrenia”ResultsMr. AA is 50 years old, has diabetes treated with metformin, hypercholesterolemia and celiac disease under gluten free diet. He has been diagnosed with schizoaffective disorder in 1992, initially put on haloperidol and carbamazepine. Since the patient wasn’t getting better, we suspected no-compliance so we switched haloperidol for fluphenazine decanoate. The patient still suffered from persecutory delusion and auditory hallucinations. We started him on clozapine still with no improvement. So, we concluded to the resistance of schizoaffective disorder considered electroconvulsive therapy (ECT). A cerebral MRI was conducted, prior to ECT, objectifying a left anterior frontal arachnoid cyst of 26 millimeters from the main axis producing a mass effect on the cerebral cortex. This neurological tumor didn’t require neurosurgery.ConclusionsOur patient was resistant to all treatments including clozapine. The only anomaly discovered was the arachnoid cyst. Could this explain the resistance of this patient and others like him? Could this be an interesting research path to further elucidate the mystery of metal disorder?DisclosureNo significant relationships.
Royal College of Psychiatrists
Title: A possible explanation for resistance in schizophrenia
Description:
IntroductionArachnoid cyst is a neurological tumor.
It’s rare and benign.
Its association to psychosis has been described in literature.
ObjectivesThrough a case report and a review of the literature we hypothesize that arachnoid cyst is the cause of resistance in a patient with schizoaffective disorder.
MethodsStarting from a case report, we conducted a literature review on “PubMed”, using key words “arachnoid cyst”, “arachnoid cyst a psychiatry”, “arachnoid cyst and schizoaffective disorder”, “arachnoid cyst and schizophrenia”ResultsMr.
AA is 50 years old, has diabetes treated with metformin, hypercholesterolemia and celiac disease under gluten free diet.
He has been diagnosed with schizoaffective disorder in 1992, initially put on haloperidol and carbamazepine.
Since the patient wasn’t getting better, we suspected no-compliance so we switched haloperidol for fluphenazine decanoate.
The patient still suffered from persecutory delusion and auditory hallucinations.
We started him on clozapine still with no improvement.
So, we concluded to the resistance of schizoaffective disorder considered electroconvulsive therapy (ECT).
A cerebral MRI was conducted, prior to ECT, objectifying a left anterior frontal arachnoid cyst of 26 millimeters from the main axis producing a mass effect on the cerebral cortex.
This neurological tumor didn’t require neurosurgery.
ConclusionsOur patient was resistant to all treatments including clozapine.
The only anomaly discovered was the arachnoid cyst.
Could this explain the resistance of this patient and others like him? Could this be an interesting research path to further elucidate the mystery of metal disorder?DisclosureNo significant relationships.
Related Results
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
T78. MORTALITY IN PATIENTS WITH SCHIZOPHRENIA ADMITTED FOR INCIDENT ISCHEMIC STROKE: A POPULATION-BASED COHORT STUDY
Abstract
Background
Evidence shows that schizophrenia is associated with increased incidence of cardiovascular diseases (CVD), i...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
T176. INSIGHTS INTO THE ROLE OF ORAL AND GUT MICROBIOME IN THE PATHOGENESIS OF SCHIZOPHRENIA
Abstract
Background
The role of oral and gut microbiomes in the pathogenesis of schizophrenia has recently come to light with th...
Causal explanation
Causal explanation
An explanation is an answer to a why-question, and so a causal explanation is an answer to ‘Why X?’ that says something about the causes of X. For example, ‘Because it rained’ as a...
Oscillatory traveling waves reveal predictive coding abnormalities in schizophrenia
Oscillatory traveling waves reveal predictive coding abnormalities in schizophrenia
AbstractThe computational mechanisms underlying psychiatric disorders are hotly debated. One hypothesis, grounded in the Bayesian predictive coding framework, proposes that schizop...
Low-concentration sevoflurane inhalation in treating MK801-induced schizophrenia like disease in mice and a feasibility study of schizophrenia patients
Low-concentration sevoflurane inhalation in treating MK801-induced schizophrenia like disease in mice and a feasibility study of schizophrenia patients
Abstract
GABAergic deficits have been considered to associate with the pathophysiology of schizophrenia and hence GABA receptor subtype A (GABAARs) modulators may have ther...
P3627Characteristics and outcomes following myocardial infarction in patients with schizophrenia
P3627Characteristics and outcomes following myocardial infarction in patients with schizophrenia
Abstract
Background
Patients with schizophrenia are a high-risk population due to a high prevalence of cardiovascular risk facto...
Dissociative Model in Patients With Resistant Schizophrenia
Dissociative Model in Patients With Resistant Schizophrenia
BackgroundSchizophrenia is a severe mental illness in which, despite the growing number of antipsychotics from 30 to 50% of patients remain resistant to treatment. Many resistance ...

